Skip to main content
. 2016 Mar 30;7(19):27584–27598. doi: 10.18632/oncotarget.8488

Figure 7. Scheme of proposed lung cancer-derived galectin-1 contributes to cancer associated fibroblast-mediated cancer progression and immune inhibition by TDO2/kynurenine axis.

Figure 7